TSBX

Turnstone Biologics Corp. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website urnstonebio.com
Employees(FY) 94
ISIN US90042W1009

Performance

+1.89%

+4.27%

-27.19%

-82.01%

-80.7%

YTD

-79.71%

Profile

Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.

Advanced Technical Analysis

Technical Analysis of TSBX 2024-12-20

The stock indicators reflect a predominantly neutral sentiment, with the Moving Average Score at 30 indicating bearish momentum, while the Oscillators Score at 50 and Technical Score at 40 suggest a lack of strong directional bias. Overall, the combined scores imply a cautious outlook for the stock, as it struggles to gain bullish traction.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of TSBX

Stock Rank

Recent News & Updates

2024-11-12 03:05
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights(Globenewswire)
2024-11-04 20:01
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting(Globenewswire)
2024-10-11 18:47
Turnstone Biologics Streamlines Operations and Leadership(Yahoo Finance)
2024-10-10 18:36
FDA clears Roche breast cancer drug; Turnstone lays off 60% of staff(Yahoo Finance)
2024-10-10 18:00
Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway(Globenewswire)
2024-08-14 09:54
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q2 2024(Investorplace)
2024-08-14 04:05
Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights(Globenewswire)
2024-08-14 04:01
Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer(Globenewswire)
2024-08-12 05:49
Turnstone Biologics Corp. (TSBX): This Penny Stock is a Strong Buy According to Analysts(Yahoo Finance)
2024-05-13 09:53
TSBX Stock Earnings: Turnstone Biologics Misses EPS for Q1 2024(Investorplace)
2024-05-13 05:01
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights(Globenewswire)
2024-05-07 21:00
Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference(Globenewswire)
2024-04-15 21:00
Turnstone Biologics Appoints William Waddill to its Board of Directors(Globenewswire)
2024-03-21 19:52
TSBX Stock Earnings: Turnstone Biologics Beats EPS for Q4 2023(Investorplace)
2024-03-21 05:06
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights(Globenewswire)
2024-02-20 17:00
Turnstone Biologics to Participate in Upcoming Investor Conferences(Globenewswire)
2024-02-20 04:00
Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.(Globenewswire)
2023-11-26 17:00
Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference(Globenewswire)
2023-11-09 08:49
Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights(Globenewswire)
2023-11-02 18:00
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting(Globenewswire)
2023-10-29 18:00
Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. Weber(Globenewswire)
2023-09-27 18:00
Turnstone Biologics to Present Preclinical Data for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy at Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting(Globenewswire)
2023-09-01 05:57
Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update(Yahoo Finance)
2023-08-14 08:41
Steven Cohen's Q2 2023 13F Filing Update: Top Trades and Portfolio Overview(Yahoo Finance)
2023-08-04 06:30
Apogee Therapeutics, Turnstone Biologics, and More Stocks See Action From Activist Investors(Yahoo Finance)
2023-07-27 07:01
Steven Cohen Acquires Stake in Turnstone Biologics Corp(Yahoo Finance)
2023-07-27 05:36
FMR LLC Acquires Significant Stake in Turnstone Biologics Corp(Yahoo Finance)
2023-07-20 14:15
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering(Yahoo Finance)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.